| Dr Andres Lambaria, OD | |
|
1063 S State Rd Ste 3, Davison, MI 48423-1900 | |
| (810) 658-2020 | |
| (810) 658-5307 |
| Full Name | Dr Andres Lambaria |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 29 Years |
| Location | 1063 S State Rd Ste 3, Davison, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508834821 | NPI | - | NPPES |
| 900B519890 | Other | MI | BLUE CROSS BLUE SHIELD |
| 4475558 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901004063 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pco Pc | 4385746320 | 3 |
News Archive
Children with a particularly lethal cancer could benefit from potentially life-saving treatment, following breakthrough work led by researchers at the University of New South Wales (UNSW).
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.
› Verified 9 days ago
| Provider Name | Pco Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1114082047 PECOS PAC ID: 4385746320 Enrollment ID: O20070222000446 |
News Archive
Children with a particularly lethal cancer could benefit from potentially life-saving treatment, following breakthrough work led by researchers at the University of New South Wales (UNSW).
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.
› Verified 9 days ago
| Provider Name | Eye Testing Specialists Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831780865 PECOS PAC ID: 3577972900 Enrollment ID: O20210514000613 |
News Archive
Children with a particularly lethal cancer could benefit from potentially life-saving treatment, following breakthrough work led by researchers at the University of New South Wales (UNSW).
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andres Lambaria, OD 2243 Abby Ct, Davison, MI 48423-8387 Ph: (810) 730-9790 | Dr Andres Lambaria, OD 1063 S State Rd Ste 3, Davison, MI 48423-1900 Ph: (810) 658-2020 |
News Archive
Children with a particularly lethal cancer could benefit from potentially life-saving treatment, following breakthrough work led by researchers at the University of New South Wales (UNSW).
Cell Therapeutics, Inc. ("CTI") announced today that, following discussions with the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"), the CHMP may issue an opinion on CTI's Marketing Authorization Application ("MAA") for Pixuvri in mid-February.
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) - a potential early warning sign of skin cancer - as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation.
An early round of clinical testing shows that users of Opdivo, a drug sanctioned for treatment of small-cell lung cancer, more than tripled their five-year survival rate beyond the statistical average.
Shire plc, today announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US.
› Verified 9 days ago
Dr. Harold Victor Steinman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1063 S State Rd, Ste. 3, Davison, MI 48423 Phone: 810-658-2456 Fax: 810-658-5307 | |
Dr. Timothy R Harris, OD PLC Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1016 S State Rd, Davison, MI 48423 Phone: 810-653-3206 | |
Lambaria Eyecare Associates Optometrist Medicare: Medicare Enrolled Practice Location: 1063 S State Rd Ste 3, Davison, MI 48423 Phone: 810-658-2020 Fax: 810-658-2021 | |
Dr. Courtney L Schneider, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1063 S State Rd Ste 3, Davison, MI 48423 Phone: 810-658-2020 Fax: 810-658-5307 | |
David M Coriasso, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1097 S State Rd, Ste 1, Davison, MI 48423 Phone: 810-653-4800 Fax: 810-412-4124 | |
Svs Vision 27 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 618 N State Rd, Davison, MI 48423 Phone: 810-742-6733 Fax: 810-742-5518 |